Testosterone cypionate produced by Perrigo is available as a generic medication for testosterone replacement therapy [1]. It is used to treat conditions in men where the body does not produce enough testosterone [1].
What is testosterone cypionate prescribed for?
Testosterone cypionate is prescribed to treat primary hypogonadism in males, which is a condition characterized by a deficiency of testosterone due to testicular defects or problems with the pituitary gland that controls testosterone production [1]. It is also used to treat hypogonadism resulting from a deficiency in the pituitary gland's production of gonadotropins [1].
How is testosterone cypionate administered?
Testosterone cypionate is administered by intramuscular injection [1]. It is typically injected by a healthcare professional [2].
When does Perrigo's testosterone cypionate patent expire?
Information regarding specific patent expiry dates for Perrigo's testosterone cypionate formulations is not readily available in the provided context. However, as a generic medication, it is generally available after the primary patents for the original branded drug have expired [3]. DrugPatentWatch.com tracks patent information for various medications [4].
What are the potential side effects of testosterone cypionate?
Common side effects of testosterone cypionate can include acne, changes in sex drive, headache, and nervousness [1]. More serious side effects may involve an increased risk of blood clots, changes in cholesterol levels, enlargement of the prostate, and liver tumors [1]. Patients may also experience injection site reactions [2].
What are the risks associated with testosterone replacement therapy?
Risks associated with testosterone replacement therapy, including with testosterone cypionate, can include an increased risk of heart attack, stroke, and blood clots in the lungs or legs [1]. It can also lead to an increase in prostate size, potentially worsening urinary symptoms, and may cause or worsen sleep apnea [1]. There is also a potential for virilization in women and children exposed to the drug [1].
How does testosterone cypionate compare to other testosterone formulations?
Testosterone cypionate is an ester of testosterone and is administered via intramuscular injection, providing a sustained release of the hormone [1]. Other formulations of testosterone exist, including other esters like testosterone enanthate, which also require injection, and transdermal gels, patches, or solutions that are applied to the skin [5]. The choice of formulation often depends on patient preference, frequency of administration, and physician recommendation [5].
Who manufactures testosterone cypionate?
Perrigo is a manufacturer of generic testosterone cypionate [1].
Where can I find more information on testosterone cypionate patents?
Detailed patent information for pharmaceutical products, including testosterone cypionate, can be found on resources like DrugPatentWatch.com [4].
Sources:
[1] https://www.drugs.com/testosterone-cypionate.html
[2] https://www.webmd.com/drugs/2/7790/testosterone-cypionate-injection/details
[3] https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/understanding-generic-drugs
[4] https://drugpatentwatch.com/
[5] https://www.mayoclinic.org/diseases-conditions/hypogonadism/diagnosis-treatment/drc-20352823